Our results are largely congruent with numerous prior studies that confirmed positive correlations between 18F-FDG PET/CT parameters and Ki67 expression in neuroendocrine tumors [18, 19], meningiomas [20], and ovarian cancers [21]. The gene discussed is MKI67; the disease is neuroendocrine neoplasm.